Marksans Pharma Limited has informed the Exchange regarding Annual General Meeting proposed to be held on August 8, 2025''.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma's Board of Directors has approved holding the 33rd Annual General Meeting on Friday, August 8, 2025 at 9:00 a.m. via Video Conferencing. The company has fixed Friday, August 1, 2025 as the Record Date to determine members eligible for the final dividend. The Board has recommended a final dividend of ₹0.80 per equity share (80% on face value of ₹1) for the financial year ended March 31, 2025, subject to shareholder approval at the AGM. If approved, the dividend will be paid on or after August 21, 2025. The Board meeting concluded in 30 minutes, indicating a routine, procedural outcome.
This is a routine, positive development for shareholders. The record date of August 1, 2025 is the key date — investors must hold shares by that date to be eligible for the ₹0.80 final dividend. The AGM and dividend proposal are procedural at this stage; share price reaction is typically muted unless dividend amount is unexpected.